Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
株式のランク #425
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health... Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
株価
$116.80
時価総額
$51.47B
変化(1日)
0.75%
変化(1年)
-27.59%
US
取引 Zoetis Inc. (ZTS)

カテゴリー

Zoetis Inc.(ZTS)のP/E比率
March 2026 時点のP/E比率 TTM 18.95
Zoetis Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は 18.95 です。2023 年末時点での P/E は 38.83 でした。
Zoetis Inc. の P/E 比率の履歴(2009 〜 2026)
各年末のP/E比率
P/E比率 変化
2026 (TTM) 18.95 -36.33%
2024 29.77 -23.34%
2023 38.83 19.46%
2022 32.51 -42.80%
2021 56.83 18.28%
2020 48.04 13.88%
2019 42.19 45.79%
2018 28.94 -29.16%
2017 40.85 26.39%
2016 32.32 -54.24%
2015 70.64 91.00%
2014 36.98 14.03%
2013 32.43 -8.80%
2012 35.56 -41.24%
2011 60.52 -55.10%
2010 134.79 -190.91%
2009 -148.27 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差
17.97 -5.19%
DE
28.23 48.92%
FR
79.35 318.66%
JP
-0.65 -103.41%
IL
22.30 17.66%
GB
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。